Trademark Search in Canada

PLEXPCR

View On IC.GC.CA

REGISTERED

on 12 Sept 2019

Last Applicant/ Owned by

SPEEDX PTY LTD

Se G16 National Innovation CentreAustralian Technology Park4 Cornwallis StreetEveleigh, New South Wales 2015

Serial Number

1762175 filed on 6^th Jan 2016

Registration Number

TMA1053909 registered on 12^th Sept 2019

Registration expiry Date

12^th Sept 2029

Correspondent Address

PERRY + CURRIER

1300 YONGE STREETSUITE 500TORONTO

ONTARIO

M4T1X3

PLEXPCR

Trademark usage description

chemicals used in science being primers and chemical preparations for scientific purposes (other than for medical or veterinary use), namely for in vi Read More

Classification Information

Class [001]
Chemicals used in science being primers and chemical preparations for scientific purposes (other than for medical or veterinary use), namely for in vitro use in biochemistry, clinical chemistry and microbiology, photography, agriculture, horticulture and forestry; reagents and reactants other than for medical or veterinary purpose, namely diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Enzymes for industrial purposes, namely for diagnostic testing purposes in the field of in vitro diagnostic use namely, for use in the diagnosis of diseases or detection or identification of pathogens; nucleic acids for laboratory use and diagnostic testing purposes; nucleic recombinant acids; acids being inorganic and organic acids being for vitro use in biochemistry, clinical chemistry, microbiology and diagnostic testing purposes; polymerase; chemicals used in food processing and screening; chemicals used in environmental monitoring being chemicals for the control of environmental pollution, reagents for use in environmental analysis, reagents for use in environmental testing.

Classification kind code

Class [005]
Pharmaceutical and veterinary preparations and substances being preparation and substances comprising of nucleic acid sequences for diagnostic and therapeutic use, including in vitro diagnostic use, namely, for use in the diagnosis of diseases or detection or identification of pathogens; reagents for medical and veterinary use being reagents comprising of nucleic acid sequences for diagnostic and therapeutic use, including diagnostic use, namely, for use in the diagnosis of diseases, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, and immune-suppression and immune disorders, for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; nucleic acid sequencing reagents for medical use for diagnostic and therapeutic use, including in vitro diagnostic use; Chemical preparations containing enzymes for medical purposes for the diagnosis of diseases or detection or identification of pathogens; Chemical preparations containing enzymes for pharmaceutical, veterinary and medical purposes for diagnostic and therapeutic use, including diagnostic use, for the diagnosis of diseases or detection or identification of pathogens; enzymes for pharmaceutical, veterinary and medical purposes, for diagnostic and therapeutic use, including diagnostic use, for the diagnosis of diseases or detection or identification of pathogens; Medical kits consisting of catalytic DNA molecules and associated detection reagents for the diagnosis of diseases, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, and immune-suppression and immune disorders, for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; Clinical diagnostics for medical and veterinary use using nucleic acid sequences, including in vitro diagnostic use, namely, for use in the diagnosis of diseases, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, and immune-suppression and immune disorders, for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; biological chemical test kits for medical laboratory use in analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders.

Classification kind code

Class [010]
Apparatus and instruments namely amplification controls quantitative polymerase chain reaction tests for use in relation to surgery, for veterinary use, for medical diagnostic and therapeutic use namely gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders; Diagnostic testing apparatus containing biomarker reagents for use in gene expression, protein expression, metabolite expression, inflammation, immune-suppression and immune disorders; Diagnostic testing kits containing biomarker reagents for use in gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders; Point of care medical devices namely amplification controls quantitative polymerase chain reaction tests for gene therapy use, namely in relation to gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders; Screening kits namely amplification controls quantitative polymerase chain reaction tests for use in relation to gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders.

Classification kind code

Mark Details

Serial Number

1762175

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 26 on 21^st Feb 2019	Approved
Submitted for opposition 27 on 3^rd Jan 2019	Approval Notice Sent
Submitted for opposition 15 on 4^th Jun 2018	Correspondence Created
Submitted for opposition 15 on 12^th Oct 2017	Correspondence Created
Submitted for opposition 15 on 9^th Jan 2017	Correspondence Created
Submitted for opposition 22 on 2^th Jun 2016	Search Recorded
Submitted for opposition 20 on 2^th Jun 2016	Examiner's First Report
Submitted for opposition 1 on 7^th Jan 2016	Created
Submitted for opposition 31 on 7^th Jan 2016	Formalized
Submitted for opposition 30 on 6^th Jan 2016	Filed